Action A004310 HYUNDAI PHARMACEUTICAL CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Hyundai Pharmaceutical Co., Ltd.

Actions

A004310

KR7004310009

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 16/07/2024 		Varia. 5j. Varia. 1 janv.
3 545 KRW +0,71 % Graphique intraday de Hyundai Pharmaceutical Co., Ltd. +1,87 % -13,75 %
2023 Hyundai Pharmaceutical Co, Ltd. (KOSE:A004310) annonce un rachat d'actions pour une valeur de 3 000 millions de KRW. CI
2023 Hyundai Pharmaceutical Co. autorise un plan de rachat. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2023 has expired with 774,546 shares, representing 2.9% for KRW 2,999.57 million.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index
Hyundai Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.
Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 23, 2022, has expired with 968,118 shares, representing 3.50% for KRW 4,388.11 million.
Hyundai Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Market Chatter: Hyundai Pharmaceutical Seeks Regulatory Approval to Market Abortion Pill in South Korea
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2008, has expired.
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on April 22, 2010, has expired.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A004310
  4. Actualités Hyundai Pharmaceutical Co., Ltd.
  5. Autres langues